NO990849D0 - Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner - Google Patents

Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner

Info

Publication number
NO990849D0
NO990849D0 NO990849A NO990849A NO990849D0 NO 990849 D0 NO990849 D0 NO 990849D0 NO 990849 A NO990849 A NO 990849A NO 990849 A NO990849 A NO 990849A NO 990849 D0 NO990849 D0 NO 990849D0
Authority
NO
Norway
Prior art keywords
aminocyclohepta
substituted
dibenzofuranamines
benzofurans
tetrahydro
Prior art date
Application number
NO990849A
Other languages
English (en)
Norwegian (no)
Other versions
NO990849L (no
Inventor
Michael E Flaugh
Jr Anton D Kiefer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO990849L publication Critical patent/NO990849L/no
Publication of NO990849D0 publication Critical patent/NO990849D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyethers (AREA)
NO990849A 1996-08-28 1999-02-23 Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner NO990849D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2474596P 1996-08-28 1996-08-28
PCT/US1997/014938 WO1998008502A1 (en) 1996-08-28 1997-08-25 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS

Publications (2)

Publication Number Publication Date
NO990849L NO990849L (no) 1999-02-23
NO990849D0 true NO990849D0 (no) 1999-02-23

Family

ID=21822177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990849A NO990849D0 (no) 1996-08-28 1999-02-23 Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner

Country Status (23)

Country Link
EP (1) EP0929299B1 (cs)
JP (1) JP2000516957A (cs)
KR (1) KR20000035942A (cs)
CN (1) CN1228695A (cs)
AT (1) ATE251457T1 (cs)
AU (1) AU741324B2 (cs)
BR (1) BR9711273A (cs)
CA (1) CA2264267A1 (cs)
CZ (1) CZ64499A3 (cs)
DE (1) DE69725459T2 (cs)
DK (1) DK0929299T3 (cs)
EA (1) EA001912B1 (cs)
ES (1) ES2208948T3 (cs)
HU (1) HUP9902901A3 (cs)
IL (1) IL128500A (cs)
NO (1) NO990849D0 (cs)
NZ (1) NZ334031A (cs)
PL (1) PL331882A1 (cs)
PT (1) PT929299E (cs)
TR (1) TR199900430T2 (cs)
UA (1) UA48245C2 (cs)
WO (1) WO1998008502A1 (cs)
YU (1) YU10499A (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
TWI263497B (en) 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
US7608629B2 (en) 2003-04-18 2009-10-27 Eli Lilly And Company (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-HT1F agonists
UA82711C2 (en) 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
CA2549007A1 (en) 2003-12-17 2005-07-07 Eli Lilly And Company Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
CN1318411C (zh) * 2005-03-21 2007-05-30 中国海洋大学 氢化轮枝霉酮类化合物及其制备方法和用途
JP5727457B2 (ja) 2009-04-02 2015-06-03 コルーシッド ファーマシューティカルズ, インコーポレイテッド 2,4,6−トリフルオロ−n−[6−(1−メチル−ピペリジン−4−カルボニル)−ピリジン−2−イル]−ベンズアミドの組成物
US8697876B2 (en) 2010-04-02 2014-04-15 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
CN102887880B (zh) * 2012-08-20 2014-10-29 东南大学 二苯并呋喃衍生物及其制备方法与用途
TWI826514B (zh) 2018-09-04 2023-12-21 美商美國禮來大藥廠 用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥
AR119319A1 (es) 2019-07-09 2021-12-09 Lilly Co Eli Procesos e intermediario para la preparación a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida y preparación de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668690A (en) * 1985-12-30 1987-05-26 Hoechst Roussel Pharmaceuticals Inc. 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans useful as analgesics, anticonvulsants or antidepressants
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine

Also Published As

Publication number Publication date
BR9711273A (pt) 1999-08-17
CZ64499A3 (cs) 1999-05-12
EP0929299B1 (en) 2003-10-08
CN1228695A (zh) 1999-09-15
UA48245C2 (uk) 2002-08-15
IL128500A0 (en) 2000-01-31
DE69725459T2 (de) 2004-08-12
ES2208948T3 (es) 2004-06-16
IL128500A (en) 2003-06-24
WO1998008502A1 (en) 1998-03-05
EP0929299A4 (en) 2000-12-20
DE69725459D1 (de) 2003-11-13
HUP9902901A2 (hu) 2000-05-28
EP0929299A1 (en) 1999-07-21
EA199900241A1 (ru) 1999-08-26
NZ334031A (en) 2000-07-28
AU741324B2 (en) 2001-11-29
JP2000516957A (ja) 2000-12-19
NO990849L (no) 1999-02-23
TR199900430T2 (xx) 1999-06-21
KR20000035942A (ko) 2000-06-26
ATE251457T1 (de) 2003-10-15
EA001912B1 (ru) 2001-10-22
AU4088097A (en) 1998-03-19
DK0929299T3 (da) 2004-02-16
YU10499A (sh) 2001-03-07
PL331882A1 (en) 1999-08-16
CA2264267A1 (en) 1998-03-05
HUP9902901A3 (en) 2002-01-28
PT929299E (pt) 2004-02-27

Similar Documents

Publication Publication Date Title
ID18249A (id) Turunan 6,5-hetero-bisiklik tersubstitusi
DK0920429T3 (da) Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
DE59712811D1 (de) 2- und 2,5-substituierte Phenylketoenole
YU15299A (sh) Farmaceutski sastavi
ID18189A (id) Dervat-derivat 6,6-hetero-bisiklik yang disubstitusi
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
TR199600358A2 (tr) -Adrenerjik agonistleri.
MA23778A1 (fr) Purine-6-ones-2,9 disubstituees
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DK0901488T3 (da) 2,4-diaminopyrimidinderivater
NO990849D0 (no) Substituerte 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyklohepta (b) benzofuraner
DE69202068D1 (de) Verschleissprüfverfahren.
NO983802L (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmåter
NO984444D0 (no) Benzothiofener, formuleringer som inneholder de samme, og fremgangsmÕter
DK1012186T3 (da) Keratinocyt-vækstfaktorer og anvendelser deraf
DE69906149D1 (de) 4,5-azolo-oxindole
PE20399A1 (es) Muteina ob
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
DE59709923D1 (de) 2- und 2,5-substituierte phenylketoenole
ES1035261Y (es) Jamonero.
DE69915055D1 (de) Antitumorale 1,5-diazaanthraquinone
TR199600579A2 (tr) N-N-Dietil-8,8-Dipropil-2-Azaspiro (4.5) Dekan-2-propanamid dimaleat.
BR9708948A (pt) 1,3 - Benzodioxois substituídos
TR199801087T2 (xx) 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application